X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (65) 65
humans (62) 62
male (46) 46
middle aged (44) 44
oncology (43) 43
female (42) 42
aged (37) 37
cancer (33) 33
adult (29) 29
care and treatment (20) 20
antineoplastic agents - adverse effects (14) 14
antineoplastic agents - therapeutic use (14) 14
neoplasms - drug therapy (14) 14
treatment outcome (14) 14
chemotherapy (12) 12
metastasis (11) 11
tumors (11) 11
carcinoma, renal cell - drug therapy (10) 10
therapy (10) 10
antineoplastic agents (9) 9
pharmacology & pharmacy (9) 9
research (9) 9
antineoplastic agents - administration & dosage (8) 8
cancer patients (8) 8
carcinoma (8) 8
head and neck neoplasms - drug therapy (8) 8
kidney neoplasms - drug therapy (8) 8
patients (8) 8
tyrosine kinase inhibitor (8) 8
young adult (8) 8
aged, 80 and over (7) 7
antimitotic agents (7) 7
antineoplastic agents - pharmacokinetics (7) 7
bevacizumab (7) 7
drug administration schedule (7) 7
head and neck neoplasms - pathology (7) 7
renal cell carcinoma (7) 7
survival (7) 7
analysis (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
breast cancer (6) 6
disease-free survival (6) 6
hematology, oncology and palliative medicine (6) 6
management (6) 6
medicine & public health (6) 6
neoplasm metastasis (6) 6
neoplasms - metabolism (6) 6
protein kinase inhibitors - adverse effects (6) 6
protein kinase inhibitors - therapeutic use (6) 6
renal-cell carcinoma (6) 6
sunitinib (6) 6
toxicity (6) 6
trial (6) 6
vascular endothelial growth factor (6) 6
adolescent (5) 5
angiogenesis inhibitors (5) 5
animals (5) 5
cancer therapies (5) 5
carcinoma, squamous cell - drug therapy (5) 5
drug therapy (5) 5
head and neck cancer (5) 5
immunohistochemistry (5) 5
immunotherapy (5) 5
indoles - adverse effects (5) 5
maximum tolerated dose (5) 5
netherlands (5) 5
niacinamide - analogs & derivatives (5) 5
oncology, experimental (5) 5
original (5) 5
pyrroles - adverse effects (5) 5
radiology, nuclear medicine & medical imaging (5) 5
retrospective studies (5) 5
solid tumors (5) 5
sorafenib (5) 5
time factors (5) 5
vascular endothelial growth factor a - antagonists & inhibitors (5) 5
angiogenesis (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
biomarkers (4) 4
carcinoma, renal cell (4) 4
carcinoma, renal cell - pathology (4) 4
clinical trials (4) 4
combination (4) 4
dendritic cells (4) 4
dose-response relationship, drug (4) 4
expression (4) 4
fatigue (4) 4
head and neck neoplasms - mortality (4) 4
head and neck neoplasms - therapy (4) 4
impact (4) 4
kidney neoplasms - pathology (4) 4
magnetic resonance imaging (4) 4
medical research (4) 4
medicine, experimental (4) 4
original article (4) 4
otorhinolaryngology (4) 4
pazopanib (4) 4
pharmacokinetics (4) 4
prevalence (4) 4
prospective studies (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e16076 - e16076
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 11/2019, Volume 80, p. 101906
Salivary gland cancer (SGC) is a rare malignancy consisting of 22 subtypes with different genetic, histological and clinical characteristics. This rarity and... 
Salivary duct carcinoma | Salivary gland neoplasms [mesh] | Antineoplastic agents [mesh] | Adenoid cystic carcinoma [mesh] | Molecular targeted therapy [mesh] | Genetics [mesh]
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 11040 - 11040
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e15596 - e15596
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 6050 - 6050
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 6056 - 6056
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2014, Volume 135, Issue 4, pp. 1007 - 1007
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. 10542 - 10542
Journal Article
International Journal of Cancer, ISSN 0020-7136, 2016, Volume 138, Issue 10, pp. 2312 - 2321
Mammalian target of rapamycin inhibitors (mTORi) have clinically significant activity against various malignancies, such as renal cell carcinoma and breast... 
toxicity | mTOR inhibitors | everolimus | interstitial lung disease | pneumonitis | MAMMALIAN TARGET | NONINFECTIOUS PNEUMONITIS | SIROLIMUS THERAPY | RENAL-CELL CARCINOMA | EVEROLIMUS THERAPY | SINGLE-AGENT | PNEUMOCYSTIS PNEUMONIA | ONCOLOGY | RANDOMIZED PHASE-II | TEMSIROLIMUS CCI-779 | ADVERSE EVENTS | Lung Diseases, Interstitial - etiology | Lung Diseases, Interstitial - metabolism | Humans | Risk Factors | Antineoplastic Agents - therapeutic use | Patient Outcome Assessment | Protein Kinase Inhibitors - adverse effects | Incidence | Neoplasms - drug therapy | TOR Serine-Threonine Kinases - antagonists & inhibitors | Neoplasms - complications | Lung Diseases, Interstitial - diagnosis | Lung Diseases, Interstitial - therapy | Signal Transduction - drug effects | Antineoplastic Agents - adverse effects | Protein Kinase Inhibitors - therapeutic use | Disease Management | Lung Diseases, Interstitial - epidemiology | Cancer patients | Care and treatment | Algorithms | Lung diseases | Cancer therapies | Mortality | TOR protein | Respiratory function | Toxicity | Lung cancer | Abnormalities | Breast cancer | Rapamycin | Management | Criteria | Disease control | Patients | Morbidity | Inhibitors | Breast | Differential diagnosis | Diagnostic systems | Diagnosis | Clear cell-type renal cell carcinoma | Cancer | Immune system | Kidney transplantation | Index Medicus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.